Pale Fire Capital SE
Source: SEC Form 13F · as of Mar 2026Pale Fire Capital SE holds 17 biotech & pharma companies tracked by BioSniper, totaling $39.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$39.7M
BioSniper AIPage context preserved
Prepared research question
What matters most for Liquidia Corp (LQDA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LQDALiquidia Corp | 388,377 | $14.7M |
| GERNGERON CORP | 4,888,304 | $7.3M |
| KURAKura Oncology, Inc. | 857,474 | $7.0M |
| RGNXREGENXBIO Inc. | 493,726 | $4.1M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 2,716,328 | $2.2M |
| SGMTSagimet Biosciences Inc. | 221,875 | $1.2M |
| XFORX4 Pharmaceuticals, Inc | 167,590 | $692K |
| AGIOAGIOS PHARMACEUTICALS, INC. | 13,650 | $462K |
| ABEOABEONA THERAPEUTICS INC. | 69,845 | $313K |
| HROWHARROW, INC. | 8,515 | $300K |
| SLNOSOLENO THERAPEUTICS INC | 8,450 | $283K |
| PTHSPelthos Therapeutics Inc. | 12,919 | $271K |
| RLMDRELMADA THERAPEUTICS, INC. | 31,650 | $220K |
| CGEMCullinan Therapeutics, Inc. | 14,218 | $202K |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | 21,350 | $200K |
| GRCEGrace Therapeutics, Inc. | 37,762 | $175K |
| IMTXImmatics N.V. | 16,272 | $160K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.